What Tablif read on Trial & Ticker's site
Trial & Ticker describes itself as: “Trial & Ticker”
- Price model: free tier
- Free tier: Free forever
- Stage: Live, no waitlist
What it is
Calls itself “Biotech Catalyst Intelligence”.
- Calls itself: Biotech Catalyst Intelligence
“Biotech Catalyst Intelligence”
What it costs
A free tier, free forever.
- Free plan: free forever
“FREE TO EXPLORE”
How it runs
A web app. Hosted in the cloud.
- Kind: web
- Runs where: cloud / hosted
“Explore the dashboard”
What it works with
Names Keytruda, Merck and 1 more on its pages.
- Names: Keytruda · Merck · XBI
“Keytruda's first approval changed Merck's story.”
“We tested our scoring method on 78 real clinical-trial readouts. For each one, we compared the score with the stock's return over the next 30 days and measured XBI over the exact same dates.”
What it offers as proof
Live, no waitlist. Claims “78”. Try it without signing up. Publishes a blog.
- Number claimed: 78
- Trial asks for: nothing
“NO SIGNUP”
“NO SIGNUP NO CREDIT CARD”
Sources
Tablif read these pages, last on 1 Nov 2026. Everything above is what the product says about itself; Tablif does not verify every claim.
Similar products in Tablif Town
- Hyper Terminal: Stock research, market catalysts, and AI-powered analysis
- Intelexus: Market intelligence for brands that compete to win
- Instama: Give AI your brand's DNA
- Genexti: Build, code & automate — one AI platform, in plain English
- Jean by Melad Labs: The bioinformatics suite for scientists and their AI
- Discover AI for Chemistry · ChemAI Atlas: Explore AI for chemistry
- Stockintelapp: The AI-powered app for stock research and market intelligence.
- Twinalyze: AI-Powered Product Analytics for Smarter Decisions